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Abstract
DOES TRANSDERMAL NICOTINE-INDUCED WITHDRAWAL SUPPRESSION
DEPEND ON SMOKERS' GENDER?
By Sarah E. Evans
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2005
Major Director: Dr. Thomas Eissenberg, Associate Professor, Department of Psychology
and Institute for Drug and Alcohol Studies
Nicotine replacement therapy (NRT) is a pharmacotherapy used commonly to
help tobacco smokers quit smoking. All forms of NRT are demonstrably efficacious for
this indication, and several forms, including transdermal nicotine (TN) are available overthe-counter in the United States. NRT is less efficacious in women than in men, although
the specific reasons for this gender difference are unknown. JRT generally, and TN
'

specifically, is thought to work, at least in part, by suppressing withdrawal symptoms in
abstinent smokers. While TN-induced withdrawal suppression has been demonstrated,
the degree to which this withdrawal suppression is influenced by smokers' gender is
uncertain. The purpose of this acute laboratory study is to determine if TN-induced
withdrawal suppression is influenced by smokers' gender.
One hundred twenty eight overnight-abstinent smokers completed four, doubleblind, randomized, 6.5-hour laboratory sessions in which further cigarette abstinence was
required. Sessions differed by TN dose (0, 7,2 1, or 42 mg). All sessions were doubleblind and randomly ordered. Each session included regular assessment of subjective
symptoms of nicotine/tobacco withdrawal, subjective effects of transdermal nicotine

dose, psychomotor performance, heart rate and plasma nicotine level. Results from this
laboratory study revealed clear nicotine dose-related effects for plasma nicotine and heart
rate, symptoms of nicotine intoxication (e.g. Nausea, Lightheaded) and suppression of
Urges to smoke and Craving. Many DSM IV nicotine/tobacco withdrawal symptoms did
not show dose-related suppression (e.g. Irritability/frustration/anger,Anxious, Difficulty
concentrating). Importantly, results from this study indicated that there were very few
differences between men and women in nicotine-induced suppression of the
nicotine/tobacco withdrawal syndrome. Future research addressing this important issue
may benefit from focusing on a potential interaction between gender and other effects of

TN (i.e., blunting the effects of a concurrently administered cigarette) and/or on other
triggers for relapse (i.e., smoking-related stimuli).

